The vast majority of thyroid cancers of follicular origin (TC) have a very favourable outcome,
but 5–10% of cases will develop metastatic disease. Around 60–70% of this subset, hence …

Whereas preemptive screening for the presence of lymph node and lung metastases is
standard-of-care in thyroid cancer patients, bone metastases are less well studied and are …

This ESMO Clinical Practice Guideline provides updated state-of-the-art recommendations
on management of thyroid cancer (diagnosis, treatment and follow-up), compiled by a …

Bone represents the second most common site of distant metastases in differentiated thyroid
cancer (DTC). The clinical course of DTC patients with bone metastases (BM) is quite …

Objectives This study aimed to establish a machine learning prediction model that can be
used to predict bone metastasis (BM) in patients with newly diagnosed thyroid cancer (TC) …

Background: Management of patients with advanced medullary thyroid cancer (MTC)
remains a therapeutic challenge. The multi-tyrosine kinase inhibitors (TKIs) vandetanib and …

Background Increasing attention has been paid to the survival of endometrial cancer (EC)
patients, but the non‐cancer causes of death from EC are rarely reported. This study …

Simple Summary Solid tumors such as prostate, breast, and lung cancers frequently spread
to bone, causing severe pain, disability, and cancer-related deaths. The multiple types of …

Distant metastasis (DM) is the dominant negative prognosis for thyroid carcinoma.
Radioactive iodine (RAI) therapy serves as an effective treatment for thyroid carcinoma …

Purpose: To investigate the association between lymph node (N) stage and clinical outcome
in thyroid cancer patients with initial distant metastasis. Methods: A total of 3,198 cases …